Hendrik Falk - Concepedia

Author

Hendrik Falk

Walter and Eliza Hall Institute of Medical Research

Also Known As

Falk, Hendrik, H. Falk, H. G. Falk, Hendrik Falk

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Walter and Eliza Hall Institute of Medical Research The University of Melbourne Monash University Commonwealth Scientific and Industrial Research Organisation Peter MacCallum Cancer Centre

About

Hendrik Falk is an author at Walter and Eliza Hall Institute of Medical Research specializing in medicine, cell biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	843
2	Cell Biology	5	5	656
3	Natural Sciences	4	4	187
4	Biochemistry	4	4	187
5	Health Sciences	1	1	170

Hendrik Falk

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth Jonathan B. Baell, David J. Leaver, S.J. Hermans, Nature Cancer ResearchChromatinTumour GrowthChromatin RemodelingMedicine	2018	300
HBO1 is required for the maintenance of leukaemia stem cells Laura MacPherson, Juliana Anokye, Miriam M. Yeung, Nature MedicineStem Cell MobilizationLeukaemia Stem CellsStem Cell ResearchStem-cell Therapy	2019	170
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production Ueli Nachbur, Che A. Stafford, Aleksandra Bankovacki, Nature Communications	2015	148
Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma Shatha AbuHammad, Carleen Cullinane, Claire Martin, Proceedings of the National Academy of Sciences Chemoprevention StrategyCancer BiologyTumor BiologyCell RegulationReceptor Tyrosine Kinase	2019	116
PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening Jonathan B. Baell, Lori Ferrins, Hendrik Falk, Australian Journal of Chemistry Pharmaceutical ScienceHit IdentificationPains FiltersOrganic ChemistryChemistry	2013	85
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer Shikhar Sharma, Chi‐Yeh Chung, Sean Uryu, Cell chemical biology	2023	59
An Efficient High-Throughput Screening Method for MYST Family Acetyltransferases, a New Class of Epigenetic Drug Targets Hendrik Falk, Theresa Connor, Hong Yang, SLAS DISCOVERY Mixed-phenotype Acute LeukemiaGeneticsEpigenetic ChangeMolecular BiologyGene Characterization	2011	56
Characterization of the Novel Broad-Spectrum Kinase Inhibitor CTx-0294885 As an Affinity Reagent for Mass Spectrometry-Based Kinome Profiling Luxi Zhang, Ian P. Holmes, Falko Hochgräfe, Journal of Proteome Research Kinase InhibitorsMolecular BiologyKinase EnrichmentAnalytical UltracentrifugationChemical Biology	2013	52
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A David J. Leaver, Benjamin Cleary, Nghi Nguyen, Journal of Medicinal Chemistry	2019	39
Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors Brad E. Sleebs, George Nikolakopoulos, Ian P. Street, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryBiochemistryMedicineNatural Sciences	2011	26

Page 1